How many institutional investors hold TXG?

4 tracked institutional investors disclosed a position in TXG (10X GENOMICS INC) in their most recent 13F filing.

Who is the largest institutional holder of TXG?

Cathie Wood, ARK Investment Management, holds the largest disclosed position in TXG, valued at $249M.

Where does this TXG ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

TXG — 10X GENOMICS INC

Name: 10X GENOMICS INC (TXG) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying TXG?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence

Institutional Conviction

Net distribution · 2 buying vs 2 selling last quarter

Macro Tailwind

Macro conditions are mixed for this sector

Why? — Evidence & Confidence ▾

Of 4 tracked investors who changed their TXG position last quarter, 2 bought and 2 sold (50% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 52/100 in a Squeeze regime).

Supporting evidence

+2 tracked investors added or increased positions last quarter (Izzy Englander, Ken Griffin)
+4 tracked investors reported holding TXG at their latest filing

Contradicting evidence — always shown

−2 tracked investors reduced or exited last quarter (2 reduced, 0 sold out)
−13F data is disclosed up to 45 days after quarter end — positions may have changed since

Know the limits

· 13F disclosure lag (up to 45 days)
· Tracked investors are a sample, not the whole market
· Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/4/2026.

About 10X GENOMICS INC (TXG)

10X GENOMICS INC (TXG) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Cathie Wood (ARK Investment Management), valued at $249M. Across recent filings, tracked investors recorded 5 new positions, 3 increased, 2 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in TXG

/100

Strong Institutional Accumulation

Added / Increased8

Reduced2

Exited0

BearishBullish

Crowded Trade Score™

How many top investors track TXG

/100

Emerging Interest

4investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

TXG Ownership Composition

How 10X GENOMICS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Growth Funds

77% of tracked value

Institutions

tracked investors

Total Reported

$321.2M

combined 13F value

Growth Funds77.4%
Other22.6%

Growth Funds(1)

77.4%

Other(3)

22.6%

Tracked investors reporting TXG

Investor	Firm	Shares	Market value	% of portfolio	As of
Cathie Wood	ARK Investment Management	11.7M	$248.8M	1.93%	Mar 31, 2026
Izzy Englander	Millennium Management	2.4M	$51.9M	0.02%	Mar 31, 2026
Ken Griffin	Citadel Advisors	931.7K	$19.8M	0.00%	Mar 31, 2026
Ray Dalio	Bridgewater Associates	35.1K	$745.2K	0.00%	Mar 31, 2026

Cathie WoodMar 31, 2026
ARK Investment Management
Shares
11.7M
Value
$248.8M
% Portfolio
1.93%
Izzy EnglanderMar 31, 2026
Millennium Management
Shares
2.4M
Value
$51.9M
% Portfolio
0.02%
Ken GriffinMar 31, 2026
Citadel Advisors
Shares
931.7K
Value
$19.8M
% Portfolio
0.00%
Ray DalioMar 31, 2026
Bridgewater Associates
Shares
35.1K
Value
$745.2K
% Portfolio
0.00%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Izzy Englander	New	—	$20.3M	Feb 17, 2026
Izzy Englander	New	—	$51.9M	May 15, 2026
Ken Griffin	Increased	275.06%	$19.8M	May 15, 2026
Ray Dalio	Reduced	-80.25%	$745.2K	May 15, 2026
Cathie Wood	Reduced	-7.50%	$248.8M	May 12, 2026
Ken Griffin	Increased	126.25%	$4.1M	Feb 17, 2026
Ray Dalio	New	—	$2.9M	Feb 13, 2026
Cathie Wood	Increased	6.56%	$206.6M	Feb 11, 2026
Ken Griffin	New	—	$1.3M	Nov 14, 2025
Cathie Wood	New	—	$139M	Nov 12, 2025

Izzy Englander
New
$20.3MFeb 17, 2026
Izzy Englander
New
$51.9MMay 15, 2026
Ken Griffin
Increased
$19.8M(275.06%)May 15, 2026
Ray Dalio
Reduced
$745.2K(-80.25%)May 15, 2026
Cathie Wood
Reduced
$248.8M(-7.50%)May 12, 2026
Ken Griffin
Increased
$4.1M(126.25%)Feb 17, 2026
Ray Dalio
New
$2.9MFeb 13, 2026
Cathie Wood
Increased
$206.6M(6.56%)Feb 11, 2026
Ken Griffin
New
$1.3MNov 14, 2025
Cathie Wood
New
$139MNov 12, 2025

Frequently asked questions

How many institutional investors hold TXG?: 4 tracked institutional investors disclosed a position in TXG (10X GENOMICS INC) in their most recent 13F filing.
Who is the largest institutional holder of TXG?: Cathie Wood, ARK Investment Management, holds the largest disclosed position in TXG, valued at $249M.
Did institutional ownership of TXG increase or decrease?: Across recent 13F filings, tracked investors recorded 5 new positions, 3 increased, 2 reduced, and 0 fully exited TXG.
Where does this TXG ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.